FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 179 - Healthcare Infection Control Practices Advisory Committee - Authorized by Law

GENERAL INFORMATION

Committee Name	Healthcare Infection Control Practices Advisory Committee	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	179
Original Establishment Date	1/19/1991	Committee Status	Terminated
Actual Termination Date	4/1/2025	Committee URL	https://www.cdc.gov/hicpac/php/upcoming-meeting...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	14
Terminated This FY	Yes	Designated Fed Officer Position Title*	Director, PRB, DHQP
Merged This FY		Designated Federal Officer Prefix	Dr.
Current Charter Date	1/19/2025	Designated Federal Officer First Name*	Alexander
Date Of Renewal Charter	1/19/2027	Designated Federal Officer Middle Name
Projected Termination Date	4/1/2025	Designated Federal Officer Last Name*	Kallen
Exempt From Renewal*	No	Designated Federal Officer Suffix	M.D.
Specific Termination Authority	E.O. 14217	Designated Federal Officer Phone*	404-639-4275
Establishment Authority*	Authorized by Law	Designated Federal Officer Fax*
Specific Establishment Authority*	42 U.S.C. 217a	Designated Federal Officer Email*	ffp0@cdc.gov
Effective Date Of Authority*	11/17/1962
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	Yes
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The Committee accomplishes its purpose by: 1) informing the development of evidence-based guidelines for the prevention of healthcare-associated infections; 2) providing infection prevention and control guidance to address new or changing infectious disease threats such as highly-pathogenic avian influenza, severe acute respiratory syndrome coronavirus 2, or antimicrobial (antibiotic) resistant pathogens; and 3) providing input on national surveillance efforts. During fiscal year 2024, the Committee continued to provide input to CDC for updates to the Guideline for Infection Control in Healthcare Personnel, and the 2007 Isolation Precautions Guideline. The Committee also provided input on improving neonatal and pediatric surveillance definitions for the National Healthcare Safety Network, which is the nation’s mostly widely used healthcare-associated infection tracking system. The committee also continues to update the Infection Control in Dental Health-Care Settings-2003, Section on Dental Unit Waterlines, Biofilm and Water Quality.
How is membership balanced?*	The Committee consists of 14 public members. In order to achieve balance, the Committee first works to ensure that necessary subject matter expertise is include; the Committee requires members with specialized experience but also broad general experience in healthcare settings to be effective. In addition, the Committee works to be balanced with respect to racial and ethnic groups, gender, geographic representation. and perspective (e.g., national, state, local). The HICPAC management team solicits new members broadly with announcements at public meetings, a Federal Register notice, and direct outreach to stakeholders. Potential members are interviewed to better understand their qualifications and decisions are made by the management group with oversight and concurrence with Division and Center leadership. The Committee’s membership currently represents expertise including, but not limited to, infectious diseases, infection prevention, healthcare epidemiology, nursing, clinical and environmental microbiology, surgery, hospitalist medicine, internal medicine, epidemiology, health policy, health services research, occupational medicine, public health, and related fields. The Committee also includes ex officio and liaison representation.
How frequent & relevant are cmte mtgs?*	Historically, the Committee has met in-person, but in fiscal year 2024 the committee met one time in person one times via video/tele-conference due to quorum and nomination package delays. Continued operation of the Committee in fiscal year 2024 and beyond is required for the ongoing development, dissemination, and evaluation of CDC's infection control guidelines to prevent healthcare-associated infections and related adverse events, prevent the emergence of antimicrobial-resistant microorganisms, and improve quality of care across the spectrum of healthcare delivery. The Committee provides critical input to CDC regarding these issues that could not be easily replaced with another mechanism.
Why advice can't be obtained elsewhere?*	CDC plays a unique role in healthcare-associated infection prevention activities in the U.S. and worldwide by developing and disseminating evidence-based infection control guidelines for preventing healthcare-associated infections and other adverse events in healthcare settings. This guidance is used by healthcare facilities in the development of local protocols and procedures for infection control. Some recommendations become infection control standards when incorporated into regulatory agency regulations (e.g., facility inspectors/surveyors such as those by Accreditation organizations or the Centers for Medicare and Medicaid Services). CDC actively investigates with State Health Departments and identifies new evidence from outbreaks of healthcare-associated infections and CDC collaborates with other federal agencies and academic partners to apply those findings to update and improve prevention guidelines. CDC also manages and leads the National Healthcare Safety Network (NHSN), the nation’s most widely used healthcare-associated infection tracking system. NHSN provides facilities, states, regions, and the nation with data from over 25,000 medical facilities to identify problem areas and measure progress of prevention efforts. In order to accomplish its mission, CDC requires input and advice from HICPAC’s recognized experts with the real-world experience in healthcare settings to optimize guidelines and recommendations, assess trends, inform ongoing improvements to healthcare-associated infection monitoring and tracking, and review policy implications relevant to prevention of healthcare-associated infections. There are no other mechanisms that can efficiently offer this breadth of coverage and experience.
Why close or partially close meetings?	N/A
Recommendation Remarks	2025 Secretary Directive-Elimination of Federal Advisory Committees Within the Department of Health and Human Services, Terminated 04.01.2025. EO 14217 Reducing the Scope of the Federal Bureaucracy. Sharon Wright, Michael Lin, Colleen Kraft, and Jennie Kwon were extended through 12/31/24. Scott Cooper as a new ex officio member for CMS, Kristen Dillon is the new ex officio member for HRSA, and Shavonna White is the new ex officio for IHS. Anurag Malani is the Liaison for IDSA since 7/4/24 replacing Eli Briggs . Justin Smyer is the Liaison for APIC and started 4/18/24 replacing Sara Smathers. Crystal Bowens started AHCA 5/13/24 replacing Pamela Truscott. Tiffany Wiksten TJC Started 4/19/24 filling a vacancy and Hilary Babcock started 12/26/23 replacing Keith Kaye. This Committee does not make formal reports. New member joined this fiscal year: Katherine Ellingson and Lela Luper started 6/28/24, Lisa Baum started 5/13/24 and Laura Evans started 12/8/23.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	Yes
Outcome Trust In Government	Yes	Action Reallocate Resources	No
Outcome Major Policy Changes	Yes	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	Yes	Action Comment	NA
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	NA	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	Healthcare associated infections cost the United States tens of millions of dollars annually. Implementation and adherence to CDC infection control guidelines that were informed from input from HICPAC potentially represent substantial cost savings for the nation and improved patient safety by reducing morbidity and mortality.	Grants Review Comment	This committee does not engage in grant review.
Number Of Recommendations*	540	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	There were 12 additional recommendations made in FY2024. 6 recommendations were made for the healthcare personnel guideline (Varicella-Zoster Virus, Measles, Mumps, Rubella, Cytomegalovirus, and Pregnant Healthcare Personnel). There were 6 recommendations made to modify the Isolation Precaution 2007 Guideline to improve clarity and to adjust recommendations in Appendix A of the guideline for Protective Environment recommendations and personal protective equipment use when caring for patients with high-consequence pathogens like viral hemorrhagic fevers (Marburg, Crimean-Congo Hemorrhagic Fever, Lassa, South American Hemorrhagic fevers, Andes Virus and Nipah Virus).	Access Agency Website	Yes
% of Recs Fully Implemented*	90.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Recommendations to the agency have been implemented and are reflected in CDC guidelines and possible CDC Guideline recommendation updates.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	10.00%	Access Publications	Yes
% of Recs Partially Implemented Comment	Sometimes recommendations from the Committee are one of several internal and external inputs that CDC might use to inform decisions (e.g., federal register public comment period, other federal agency review, etc). Also, some recommendations will not be implemented until CDC Guidelines are published. CDC is currently working to refine, finalize, and publish the surveillance methods and guidelines that are informed by Committee's input.	Access Other	Yes
Agency Feedback*	Yes	Access Comment	Public Meetings
Agency Feedback Comment*	The agency provides feedback to the committee through updates at regularly scheduled meetings and email communication to notify the HICPAC when action has been taken based on their recommendations. Draft recommendations are presented in the Federal Register for public review and comment as part of our routine processes. In addition, deliberations and feedback is recorded in the HICPAC meeting minutes published our the HICPAC website for public viewing.	Narrative Description*	CDC's mission is to protect America from health safety and security threats and to increase quality of life by preventing and controlling disease, injury, and disability. The agency accomplishes its mission by working with partners to monitor health, develop and advocate sound public health policies, and implement prevention strategies. The Healthcare Infection Control Practices Advisory Committee supports CDC's mission by providing input into CDC's guidelines and recommendations for prevention of healthcare-associated infections (HAIs) and antimicrobial resistance. HICPAC also supports the CDC mission by providing strategy for surveillance as well as monitoring and tracking HAIs to improve patient safety in U.S. healthcare facilities.

COSTS

1. Payments to Non-Federal Members*		1. Est Paymnts to Non-Fed Membrs Nxt FY*	$0.00
2. Payments to Federal Members*		2. Est. Payments to Fed Members Next FY*	$0.00
3. Payments to Federal Staff*		3. Estimated Payments to Federal Staff*	$0.00
4. Payments to Consultants*		4. Est. Payments to Consultants Next FY*	$0.00
5. Travel Reimb. For Non-Federal Membrs*		5. Est Travel Reimb Non-Fed Membr nxtFY*	$0.00
6. Travel Reimb. For Federal Members*		6. Est Travel Reimb For Fed Members*	$0.00
7. Travel Reimb. For Federal Staff*		7. Est. Travel Reimb to Fed Staf Nxt FY*	$0.00
8. Travel Reimb. For Consultants*		8. Est Travel Reimb to Consltnts Nxt FY*	$0.00
10. Other Costs		10. Est. Other Costs Next FY*	$0.00
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	3/14/2025 9:43 AM	Est. Fed Staff Support Next FY*	0.00
Federal Staff Support (FTE)*		Est Cost Remarks	The Committee was terminated effective March 31, 2025, under E.O. 14217, Commencing the Reduction of the Federal Bureaucracy.
Cost Remarks

Interest Areas

Category Area Basic Science Microbiology Food and Drugs Medical Devices Health Health Care Hospitals Medical Education Medical Practitioners Public Health Safety Labor Occupational Safety and Health Medicine Diseases Health and Health Research Illnesses Medicine and Dentistry

Custom Links

Committee Level Reports